Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: A single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME)

Transfusion

Volumn 51, Issue 12, 2011, Pages 2620-2626

  Thiele, Thomas ^a,b   Krüger, William ^a,b   Zimmermann, Kathrin ^a,b   Ittermann, Till ^a,b   Wessel, Antje ^a,b   Steinmetz, Ivo ^a,b   Dölken, Gottfried ^a,b   Greinacher, Andreas ^a,b  

^a Institut für Immunologie und Transfusionsmedizin   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; THROMBOCYTE CONCENTRATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; BLOOD COMPONENT THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOREDUCED BLOOD PRODUCT TRANSFUSION; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION;

ANTIBODIES, VIRAL; BLOOD COMPONENT TRANSFUSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DONOR SELECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKAPHERESIS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 83555173550     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03203.x     Document Type: Article

References (23)

1. Reusser P, Riddell SR, Meyers JD, Greenberg PD,. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78: 1373-80.
2. Clark DA, Emery VC, Griffiths PD,. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. Semin Hematol 2003; 40: 154-62. (Pubitemid 36461093)
3. Smith D, Lu Q, Yuan S, Goldfinger D, Fernando LP, Ziman A,. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction versus cytomegalovirus-seronegative. Vox Sang 2010; 98: 29-36.
4. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W,. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86: 3598-603.
5. Vamvakas EC,. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 2005; 19: 181-99. (Pubitemid 40943570)
6. Nichols WG, Price TH, Gooley T, Corey L, Boeckh M,. Transfusion- transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003; 101: 4195-200. (Pubitemid 36857904)
7. Arbeitskreis-Blut. Humanes cytomegalievirus (HCMV). Bundesgesundheitsbl- gesundheitsforsch-gesundheitsschutz 2000; 43: 653-9.
8. Lubeck PR, Doerr HW, Rabenau HF,. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol 2010; 199: 53-60.
9. Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H,. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion. Transfusion 2007; 47: 1972-83. (Pubitemid 47623966)
10. Ottinger HD, Muller CR, Goldmann SF, Albert E, Arnold R, Beelen DW, Blasczyk R, Bunjes D, Casper J, Ebell W, Ehninger G, Eiermann T, Einsele H, Fauser A, Ferencik S, Finke J, Hertenstein B, Heyll A, Klingebiel T, Knipper A, Kremens B, Kolb HJ, Kolbe K, Lenartz E, Grosse-Wilde H, et al,. Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol 2001; 80: 706-14. (Pubitemid 34041427)
11. Kluter H, Dorges L, Maass E, Wagner T, Bartels H, Kirchner H,. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats. Ann Hematol 1996; 73: 85-9. (Pubitemid 26270953)
12. Misterek J, Muller K, Bux J, Mueller-Eckhardt C,. Preparation of leukocyte-poor platelet concentrates from buffy coats by a new type of quadruple bag. Blut 1990; 60: 28-30. (Pubitemid 20065926)
13. van der Meer P, Pietersz R, Reesink H,. Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers. Vox Sang 2001; 81: 102-7. (Pubitemid 35369985)
14. Zeiler T, Kretschmer V,. In-line leukocyte depletion of thrombocytapheresis concentrates with the Fresenius-AS-104 cell separator. Beitr Infusionsther Transfusionsmed 1997; 34: 110-3.
15. Chabanel A, Andreu G, Carrat F, Herve P,. Quality control of leucoreduced cellular blood components in France. Vox Sang 2002; 82: 67-71. (Pubitemid 36806462)
16. Richter E, Matthes G, Tofoté U, Rath E, Takahashi TA, Hosoda M, Sekiguchi S,. 4-Log leukocyte depletion of erythrocyte concentrates-a comparison with 3 other filters. Beitr Infusionsther Transfusionsmed 1994; 32: 26-8.
17. Espy MJ, Smith TF,. PCR detection of cytomegalovirus DNA sequences in clinical specimens. In:, Persing DH, Smith TF, Tenover FC, White TJ, editors. Diagnostic molecular microbiology: principles and applications. Washington (DC): American Society for Microbiology; 1993. p. 332-6.
18. Machida U, Kami M, Fukui T, Kazuyama Y, Kinoshita M, Tanaka Y, Kanda Y, Ogawa S, Honda H, Chiba S, Mitani K, Muto Y, Osumi K, Kimura S, Hirai H,. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 2000; 38: 2536-42. (Pubitemid 30485125)
19. Altman DG, Machin D, Bryant T, Gardner MJ,. Statistics with confidence: confidence intervals and statistical guidelines. London: BMJ Books; 2000.
20. Narvios AB, Lichtiger B,. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study. Haematologica 2001; 86: 749-52. (Pubitemid 32681002)
21. Narvios AB, de Lima M, Shah H, Lichtiger B,. Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients. Bone Marrow Transplant 2005; 36: 499-501. (Pubitemid 43118143)
22. Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M,. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant 2002; 29: 599-606. (Pubitemid 34537721)
23. Wu Y, Zou S, Cable R, Dorsey K, Tang Y, Hapip CA, Melmed R, Trouern-Trend J, Wang JH, Champion M, Fang C, Dodd R,. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction. Transfusion 2010; 50: 776-86.